Update on Adjuvant Chemotherapy for Early Breast Cancer

Breast cancer is the second most common cancer in women worldwide. Although most women are diagnosed with early breast cancer, a substantial number recur due to persistent micro-metastatic disease. Systemic adjuvant chemotherapy improves outcomes and has advanced from first-generation regimens to mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rampurwala, Murtuza M, Rocque, Gabrielle B, Burkard, Mark E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197909/
https://www.ncbi.nlm.nih.gov/pubmed/25336961
http://dx.doi.org/10.4137/BCBCR.S9454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197909/
https://www.ncbi.nlm.nih.gov/pubmed/25336961
http://dx.doi.org/10.4137/BCBCR.S9454

Ejemplares similares